Zum Hauptinhalt springen

Polymyxin Resistance in Clinical Isolates of K. pneumoniae in Brazil: Update on Molecular Mechanisms, Clonal Dissemination and Relationship With KPC-Producing Strains.

Conceição-Neto, OC ; da Costa BS ; et al.
In: Frontiers in cellular and infection microbiology, Jg. 12 (2022-07-15), S. 898125
Online academicJournal

Titel:
Polymyxin Resistance in Clinical Isolates of K. pneumoniae in Brazil: Update on Molecular Mechanisms, Clonal Dissemination and Relationship With KPC-Producing Strains.
Autor/in / Beteiligte Person: Conceição-Neto, OC ; da Costa BS ; Pontes, LDS ; Silveira, MC ; Justo-da-Silva, LH ; de Oliveira Santos IC ; Teixeira, CBT ; Tavares E Oliveira, TR ; Hermes, FS ; Galvão, TC ; Antunes, LCM ; Rocha-de-Souza, CM ; Carvalho-Assef, APD
Link:
Zeitschrift: Frontiers in cellular and infection microbiology, Jg. 12 (2022-07-15), S. 898125
Veröffentlichung: Lausanne : Frontiers Media SA, 2022
Medientyp: academicJournal
ISSN: 2235-2988 (electronic)
DOI: 10.3389/fcimb.2022.898125
Schlagwort:
  • Brazil
  • Humans
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • Polymyxins adverse effects
  • Polymyxins pharmacology
  • Polymyxins therapeutic use
  • Anti-Bacterial Agents pharmacology
  • Anti-Bacterial Agents therapeutic use
  • Colistin pharmacology
  • Colistin therapeutic use
  • Drug Resistance, Bacterial drug effects
  • Drug Resistance, Bacterial genetics
  • Klebsiella Infections epidemiology
  • Klebsiella Infections genetics
  • Klebsiella pneumoniae genetics
  • Klebsiella pneumoniae isolation & purification
  • beta-Lactamases genetics
  • beta-Lactamases therapeutic use
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [Front Cell Infect Microbiol] 2022 Jul 15; Vol. 12, pp. 898125. <i>Date of Electronic Publication: </i>2022 Jul 15 (<i>Print Publication: </i>2022).
  • MeSH Terms: Anti-Bacterial Agents* / pharmacology ; Anti-Bacterial Agents* / therapeutic use ; Colistin* / pharmacology ; Colistin* / therapeutic use ; Drug Resistance, Bacterial* / drug effects ; Drug Resistance, Bacterial* / genetics ; Klebsiella Infections* / epidemiology ; Klebsiella Infections* / genetics ; Klebsiella pneumoniae* / genetics ; Klebsiella pneumoniae* / isolation & purification ; beta-Lactamases* / genetics ; beta-Lactamases* / therapeutic use ; Brazil ; Humans ; Microbial Sensitivity Tests ; Multilocus Sequence Typing ; Polymyxins / adverse effects ; Polymyxins / pharmacology ; Polymyxins / therapeutic use
  • References: Antimicrob Agents Chemother. 2009 Aug;53(8):3365-70. (PMID: 19506063) ; Clin Microbiol Infect. 2006 Apr;12(4):315-21. (PMID: 16524407) ; Antimicrob Agents Chemother. 2010 Jan;54(1):24-38. (PMID: 19721065) ; J Antimicrob Chemother. 2018 Oct 1;73(10):2782-2788. (PMID: 30010894) ; Braz J Infect Dis. 2017 Jan - Feb;21(1):98-101. (PMID: 27832961) ; Nat Commun. 2020 Feb 7;11(1):769. (PMID: 32034139) ; Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61. (PMID: 11257029) ; Clin Infect Dis. 2020 Oct 23;71(7):e141-e150. (PMID: 31712802) ; FEBS Lett. 1998 Mar 20;425(1):1-6. (PMID: 9540996) ; Antimicrob Agents Chemother. 2014 Oct;58(10):5696-703. (PMID: 25022583) ; Pathog Glob Health. 2017 Jun;111(4):166-175. (PMID: 28395597) ; J Antimicrob Chemother. 2009 Apr;63(4):654-8. (PMID: 19218573) ; Annu Rev Microbiol. 2019 Sep 8;73:507-528. (PMID: 31226026) ; Emerg Microbes Infect. 2020 Dec;9(1):508-516. (PMID: 32116151) ; Microb Genom. 2018 Feb;4(2):. (PMID: 29424684) ; J Biomed Sci. 2010 Jul 24;17:60. (PMID: 20653976) ; Int J Med Microbiol. 2020 Oct;310(7):151448. (PMID: 33092694) ; Braz J Microbiol. 2016 Dec;47 Suppl 1:31-37. (PMID: 27825605) ; Int J Antimicrob Agents. 2014 Dec;44(6):500-7. (PMID: 25264127) ; Virulence. 2017 May 19;8(4):470-484. (PMID: 28276996) ; Antimicrob Agents Chemother. 2011 Jul;55(7):3579-83. (PMID: 21576442) ; Nucleic Acids Res. 2021 Jan 8;49(D1):D344-D354. (PMID: 33156333) ; Emerg Infect Dis. 2016 Oct;22(10):1849-51. (PMID: 27648951) ; J Glob Antimicrob Resist. 2014 Mar;2(1):11-16. (PMID: 27873631) ; Antimicrob Agents Chemother. 2016 Oct 21;60(11):6969-6972. (PMID: 27620478) ; Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988) ; Biosci Biotechnol Biochem. 2019 Apr;83(4):684-694. (PMID: 30632929) ; Arch Microbiol. 2018 Jul;200(5):793-802. (PMID: 29423561) ; Clin Microbiol Infect. 2013 Jan;19(1):E23-E30. (PMID: 23137235) ; J Bacteriol. 2020 Jun 1;:. (PMID: 32482726) ; J Antimicrob Chemother. 2014 Oct;69(10):2713-22. (PMID: 24917579) ; Ann Intensive Care. 2015 Dec;5(1):61. (PMID: 26261001) ; Clin Infect Dis. 2012 Oct;55(7):943-50. (PMID: 22752516) ; J Antibiot (Tokyo). 2014 Feb;67(2):147-51. (PMID: 24169795) ; Antimicrob Agents Chemother. 2015 May;59(5):2909-13. (PMID: 25691646) ; Clin Microbiol Rev. 2017 Apr;30(2):557-596. (PMID: 28275006) ; J Antimicrob Chemother. 2018 Jun 1;73(6):1604-1610. (PMID: 29514208) ; Trends Microbiol. 2011 Dec;19(12):588-95. (PMID: 22078325) ; J Microbiol Methods. 2018 Oct;153:35-39. (PMID: 30144479) ; Mol Microbiol. 2007 Jan;63(1):283-93. (PMID: 17229213) ; Euro Surveill. 2018 Feb;23(6):. (PMID: 29439754) ; Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641. (PMID: 30976793) ; PLoS One. 2015 Sep 04;10(9):e0136813. (PMID: 26340563) ; Front Microbiol. 2014 Nov 26;5:643. (PMID: 25505462) ; Annu Rev Microbiol. 2019 Sep 8;73:175-197. (PMID: 31100988) ; Foodborne Pathog Dis. 2006 Spring;3(1):59-67. (PMID: 16602980) ; J Antimicrob Chemother. 2013 Feb;68(2):312-6. (PMID: 23070735) ; Int J Antimicrob Agents. 2015 Jul;46(1):108-10. (PMID: 25982250) ; Sci Rep. 2020 Jan 27;10(1):1232. (PMID: 31988374) ; Nat Commun. 2015 Nov 13;6:8838. (PMID: 26564787) ; Int J Antimicrob Agents. 2021 Nov;58(5):106426. (PMID: 34419579) ; PLoS One. 2015 Jul 21;10(7):e0133727. (PMID: 26196384) ; Antimicrob Agents Chemother. 2014 Aug;58(8):4762-6. (PMID: 24914122) ; Emerg Infect Dis. 2014 Jul;20(7):1170-5. (PMID: 24959688) ; Int J Antimicrob Agents. 2017 Sep;50(3):503-504. (PMID: 28729123) ; Lancet Infect Dis. 2017 Feb;17(2):153-163. (PMID: 27866944) ; Antimicrob Agents Chemother. 2015 May;59(5):2780-4. (PMID: 25733503) ; Lancet Infect Dis. 2016 Feb;16(2):161-8. (PMID: 26603172) ; ACS Chem Biol. 2015 Jan 16;10(1):213-24. (PMID: 25436989) ; Microbiol Spectr. 2022 Feb 23;10(1):e0176621. (PMID: 35171013) ; Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. (PMID: 26278669)
  • Contributed Indexing: Keywords: Klebsiella pneumoniae; PhoPQ and PmrAB; antibiotic resistance; mcr gene; polymyxin resistance
  • Substance Nomenclature: 0 (Anti-Bacterial Agents) ; 0 (Polymyxins) ; EC 3.5.2.6 (beta-Lactamases) ; Z67X93HJG1 (Colistin)
  • Entry Date(s): Date Created: 20220801 Date Completed: 20220802 Latest Revision: 20220809
  • Update Code: 20231215
  • PubMed Central ID: PMC9334684

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -